Novartis' Busy Week
NJBIZ, Mar 12, 2007
A tablet that inhibits an enzyme produced by the kidney and an antifungal ointment were on the menu for Novartis last week. The Swiss drugmaker received approval from the U.S. Food and Drug Administration for Tekturna, a blood pressure medicine that is the first approved by the federal agency to repress renin, an enzyme in the kidney that plays a role in regulating blood pressure.
Novartis, whose U.S. headquarters is in East Hanover, also announced it will help Princeton-based Barrier Therapeutics to market Vusion Ointment, the specially pharmaceutical company's salve for diaper rash that has been aggravated by Candida, a fungus.
Copyright Journal Publications Inc. Mar 12, 2007
Provided by ProQuest Information and Learning Company. All rights Reserved
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Content provided in partnership with
Most Recent Business Articles
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- LIFO vs. FIFO: a return to the basics
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Using object-oriented analysis and design over traditional structured analysis and design
- Design a commission plan that drives sales - Sales Commissions
Presented by American Express